New President Committed to Booming Future

February 10, 2021

Daniel Kagan is now President of He was previously Vice President of Research and Chief Operating Officer, roles in which he succeeded in substantially growing the company—from $11M in sales in 2015 to $265M USD in 2020. Now, he plans to launch BaaS (Biotech-as-a-service), a service that will aid researchers in minimizing wasted time and will speed progress.

According to Kevin Lustig, CEO of, “Dan has played a critical role in’s meteoric rise over the last six years, touching nearly every aspect of the organization,” adding, “His exceptional leadership, clear-sighted vision and legendary work ethic have helped the company take huge steps toward achieving its mission to empower scientists and make it possible to cure all human diseases by 2050.” Read more here.

(Source: Business Wire, 2/9/21)

Share This Story!